Our History & Mission
AIBMR is a scientific and regulatory consulting firm founded in 1978. We are one of the oldest natural products consulting firms in North America, focusing on Independent GRAS conclusions (Self-Affirmed GRAS or GRAS Self-Determinations), FDA GRAS conclusions, FDA NDI notifications, toxicology studies, scientific publications and general FDA and FTC regulatory compliance, such as label reviews and claims substantiations for the food and dietary supplement industries. We maintain an extensive scientific and natural products library, including a rare botanical medicine collection.
Our team is especially unique, as it is comprised of naturopathic physicians, as well as a PhD scientist and a registered dietitian. Naturopathic physicians are licensed as primary care physicians in a number of U.S. states, and are trained in medicinal diagnostics and pharmaceutical treatments along with natural medicine modalities, including nutrition, botanical medicine, pharmacognosy, behavioral sciences, homeopathy, preventative medicine, lifestyle counseling, and dietary supplements. In addition, our staff has training and experience in toxicology, basic science and clinical research, biostatistics & epidemiology, dietetics, library sciences and decades of experience in FDA and FTC regulatory consulting and toxicological sciences, collectively providing a unique perspective for our clients in the food and supplement industries.
Alexander Schauss, PhD, FACN, CFS
AIBMR’s founder, Dr. Schauss, is a leader in nutraceutical research and consulting. He is uncompromising in pursuing the highest quality research standards for AIBMR Life Science’s clients while helping them profit. Dr. Schauss has built an extensive world-wide professional network and gathered an immeasurable pool of knowledge and experience. His expertise extends to introducing AIBMR Life Science’s clients to this network, offering secure, responsible and trustworthy working relationships with competent partners.Read More
Alexander Schauss, PhD, FACN, is the Senior Research Director of Natural and Medicinal Products Research, and CEO at AIBMR Life Sciences, with offices in Arizona, Colorado, and Washington. As lead scientist, Dr. Schauss has worked on projects in 55 countries for AIBMR to support research activities for over 500 companies or institutions. He earned his undergraduate, graduate (summa cum laude), and doctoral degrees at the University of New Mexico at Albuquerque and, California Coast University in Santa Ana, respectively, completing post-graduate studies or continuing education at the University of New Mexico, the University of Washington at Seattle, University of Washington at Tacoma, the University of Puget Sound, the University of Texas Medical Branch at Galveston, Stanford University, Georgia State University, University of Georgia, and California State University – Fullerton. Currently, he is a Research Associate in the College of Science at the University of Arizona in Tucson.
Dr. Schauss has studied nutrition and botanical medicine since 1969, when he performed his first clinical trial on the use of high dose oral vitamin C and its effects on opioid receptors in the treatment of heroin addiction; a landmark study that attracted the attention of two-time Nobel Laureate, Dr. Linus Pauling. Since then he has held a number of academic positions, including Clinical Professor of Natural Products Research and Adjunct Research Professor of Botanical Medicine at the National College of Natural Medicine in Portland, Oregon; Senior Director of the Southwest College Research Institute in Scottsdale, Arizona; Associate Professor of Research at the Southwest College of Naturopathic Medicine and Health Sciences in Tempe, Arizona; Director, Institute for Biosocial Research, City University, Seattle; and, Lecturer in Biostatistics and Epidemiology at Bastyr University in Seattle.
He has been a member of the National Institutes of Health (NIH) Office of Alternative Medicine (OAM) Advisory Council (AMPAC); a member of the Ad Hoc Developmental Planning Committee of the NIH Office of Dietary Supplements (ODS); a reviewer of botanical standards and information monographs for the U.S. Pharmacopoeia Convention (USP); and, a reviewer for the International Bibliographic Information on Dietary Supplements (IBIDS) database, maintained through an interagency partnership with the Food and Nutrition Information Center, National Agricultural Library, and U.S. Department of Agriculture (USDA). Currently, he serves on one of the expert panels of USP through 2015.
In 1985, Dr. Schauss was appointed to represent the United States as a voting member to the World Health Organization (WHO) Study Group on Health Promotion, based on the recommendation of the Director General of WHO, Dr. Hafdan Mahler, leading to his confirmation by the Secretary of the U.S. Department of Health and Human Services.
He is a member in good standing of the American Society of Nutrition, the Society for Experimental Biology in Medicine, the Society for Food Science and Technology, the American College of Toxicology, a Fellow of the American College of Nutrition (FACN), International Society of Regulatory Toxicology and Pharmacology, the American Chemical Society, and Society of Toxicology. He is also an Emeritus Member of the New York Academy of Sciences, former Chairman of the Food Policy Council of the National Council for Public Health Policy, an Honorary Founding Member of the British Society of Nutritional Medicine, and Emeritus Executive Director of the American Preventive Medical Association.
In 2005, Dr. Schauss received the Linus Pauling Lecture Award “for contributions to the medical sciences” from the American College for the Advancement of Medicine. In 1996 he was an official NGO member of the US FDA delegation to the Codex Meeting on Special Nutritionals held in Bonn, Germany. In 2006, Dr. Schauss is credited with originating Supplementology™, defined as technical consultation in the field of research, development and formulation of nutraceutical, botanical and natural preparations.
Besides having chaired and served on numerous Generally Recognized As Safe (GRAS) self-affirmation expert panels, since 1991 Dr. Schauss has chaired the Safety Subcommittee of the Compliance and Labeling Integrity Committee (ComPLI) of the Natural Products Association (NPA), the nation’s largest natural products trade association, founded in 1935. ComPLI oversees the association’s GMP certification program, its TruLabel Program, and makes recommendations to the Board of Directors regarding quality and purity standards for nutraceutical products sold by over 10,000 members of the association.
He is an Associate Editor of the Journal of Orthomolecular Medicine, along with John Hoffer, MD, PhD, FRCPC, at McGill University, Canada. From 1979 to 1992, Dr. Schauss served as Editor-in-Chief of the International Journal of Biosocial and Medical Research. Currently, he reviews manuscript submissions for 21 peer review journals.
He is the author or co-author of nearly 250 publications that have appeared in a diverse range of scientific journals, including: Atherosclerosis, Experimental Gerontology, Toxicology, Journal of Agricultural and Food Chemistry, Food Chemistry, Regulatory Toxicology and Pharmacology, Renal Failure, Food and Chemical Toxicology,International Journal of Neurology, International Journal of Toxicology, Nutrition Research, Biological Trace Element Research, Journal of Nutritional Biochemistry, Journal of Medicinal Food, and, the Journal of the American College of Nutrition.
Besides being the author/co-author of 23 books in the fields of nutrition and botanical medicine, some of which have been published in numerous languages, Dr. Schauss has contributed 36 chapters to a wide range of edited works, including chapters in all editions of the Textbook of Natural Medicine (Elsevier Science: Oxford, UK); the review chapter on tocotrienols in the definitive work, Tocotrienols: Vitamin E Beyond Tocopherols (CRC Press: Boca Raton, FL), and the forthcoming second edition, on the safety of tocotrienols; culinary spices in cancer chemoprevention, in Bioactive Foods and Extracts – Cancer Treatment and Prevention (CRC Press, Taylor & Francis: Boca Raton, FL); three chapters in Bioactive Foods in Promoting Health (Academic Press: Oxford, UK); and chapters in such forthcoming works as: Botanical Foods in Cancer Treatment and Prevention (Academic Press: Oxford, UK); Dried Fruits – Phytochemicals and Health Applications (Blackwell/Wiley & Sons: Chichester, UK); Bioactive Foods as Dietary Interventions for Arthritis and Related Inflammatory Diseases (Elsevier: Oxford, UK), and Fruits, Vegetables, and Herbs: Bioactive Foods in Health Promotion (Academic Press, Oxford).
John R. Endres, ND
Chief Scientific Officer
Dr. Endres, ND has been AIBMR Life Science’s Chief Scientific Officer since 2006. He coordinates a team of scientific and regulatory consultants to the functional foods and dietary supplement industries. Dr. Endres helps AIBMR Life Science’s clients to meet their goals by working closely with them to develop practical research strategies. He is very involved with GRAS Self-determinations, FDA GRAS Notifications, FDA NDI Notifications, regulatory compliance, and toxicology studies at AIBMR. Dr. Endres offers professional and personalized service every step of the way with the highest degree of integrity and attention to detail.Read More
Dr. Endres is the chief scientific officer for AIBMR Life Sciences, Inc. in Seattle, Washington. Dr. Endres earned a degree in naturopathic medicine at Bastyr University in Kenmore, Washington in 2004 and is licensed by Washington State Department of Health as a physician. He is a full member of the Society of Toxicology (SOT). Dr. Endres has been a member of numerous expert panels assembled for the evaluation of GRAS Self-determinations. He meets frequently with FDA Office of Food Additive Safety (OFAS) in College Park, MD for FDA GRAS pre-notification meetings. Dr. Endres has been a contributing author on many safety assessments published in academic journals specializing in toxicology. He is frequently the monitoring scientist for toxicology studies designed to study the safety of ingredients to be added to foods and dietary supplements. Dr. Endres is on the Editorial Advisory Boards for Nutritional Outlook, Functional Ingredients, and is on the Executive Advisory Board for Vitafoods Europe. Most recently he became one of 33 voting members on the NSF International Joint Committee to develop Publically Available Standards (PAS) for GRAS on behalf of the Grocery Manufacturers Association (GMA). At AIBMR, he manages a team of scientific and regulatory consultants specializing in the natural products and functional foods industries.
Prior to his work at AIBMR, Dr. Endres was involved in cancer research conducted at the Bastyr University Research Institute (BURI) and Fred Hutchinson Cancer Research Center, both located in Seattle, Washington. He screened botanical extracts for their inhibitory effect on the growth of various cancer cell lines. A particular area of interest was garlic plant parts in various breast cancer cell lines as well as the anti–proliferative effects of Curcuma longa (turmeric) on various colon cancer cell lines. He has also been the recipient of grants to present research in the United Kingdom at Westminster University, Middlesex University, and Oxford Natural Products. He has also presented research at various venues, including American Medical Association sponsored conferences where, in 2001, he received an Award of Excellence in Research. Dr. Endres was a teaching assistant in laboratory chemistry and a research assistant in natural products research, with a focus on production, purification, and analytical chemistry of whole plant extracts while attending Bastyr University.
Amy Clewell, ND, DABT
Vice President, Scientific and Regulatory Affairs
Dr. Clewell specializes in safety evaluations of dietary ingredients, especially in the form of General Recognition of Safety (GRAS) independent conclusions and FDA notifications, as well as New Dietary Ingredient (NDI) notifications. She is also involved in writing scholarly manuscripts for peer-reviewed journal publications, trade journals and technical reports, and in evaluating and compiling laboratory and clinical research on natural ingredients, responding to regulatory compliance inquiries related to food and dietary supplements, aiding in claim substantiations, label reviews and performing due diligence reviews.Read More
Dr. Amy Clewell is Vice President, Scientific and Regulatory Affairs at AIBMR Life Sciences. Dr. Clewell earned a Bachelor of Science degree in biology from Indiana University in Bloomington, Indiana and a doctoral degree in Naturopathic Medicine from Bastyr University in Kenmore, Washington. She maintains her physician’s license in the State of Washington. She is a Diplomate of the American Board of Toxicology (DABT), and is a full member of the Society of Toxicology (SOT). She has been a member of numerous expert panels assembled for the evaluation of Independent General Recognition of Safety (GRAS) Conclusions of food ingredients. Dr. Clewell is an author on many peer–reviewed journal publications, especially related to the toxicological evaluation of food ingredients. Her authorship also includes book chapters and trade articles. She has over 9 years of experience in natural products regulatory consulting, and specializes in the preparation of Independent GRAS dossiers, as well as FDA GRAS and New Dietary Ingredient (NDI) notifications. She is also involved in the evaluation and compilation scientific research on the efficacy of ingredients and regulatory compliance for natural products. She plays a strong role in the management of projects at AIBMR Life Sciences.
In addition to work at AIBMR, Dr. Clewell has clinical experience as a licensed physician in Washington State, as well as extensive research experience. Her work in research began as a student and laboratory technician as an undergraduate at Indiana University where she spent three years working in the area of translational initiation using Saccharomyces cerevisiae as a model system. She continued her research pursuits for another five years as a research technician and laboratory manager in Dr. Karla Kirkegaard’s laboratories at both the University of Colorado and Stanford University, studying the biochemistry of polio and hepatitis C virus propagation using an S. cerevisiae model. She remained active in research in various capacities while attending Bastyr University for her doctorate.
She is the past-president of the Indiana Association of Naturopathic Physicians and a current member of the American Association of Naturopathic Physicians.
Timothy Murbach, ND, DABT
Senior Scientific and Regulatory Consultant
Timothy Murbach, ND, DABT is a Senior Scientific & Regulatory Consultant at AIBMR Life Sciences. Dr. Murbach received his doctor of naturopathic medicine, with high honors, from the National University of Natural Medicine in Portland, Oregon and currently maintains his naturopathic physician’s license in the State of Washington (previously having been licensed in Oregon and California). He earned a bachelor of science degree in biology, with a minor in chemistry, from Oregon State University, graduating summa cum laude. Dr. Murbach is a diplomate of the American Board of Toxicology and a full member of the Society of Toxicology.Read More
Timothy Murbach, ND, DABT is a Senior Scientific & Regulatory Consultant at AIBMR Life Sciences. Dr. Murbach received his doctor of naturopathic medicine, with high honors, from the National University of Natural Medicine in Portland, Oregon and currently maintains his naturopathic physician’s license in the State of Washington (previously having been licensed in Oregon and California). He earned a bachelor of science degree in biology, with a minor in chemistry, from Oregon State University, graduating summa cum laude. Dr. Murbach is a diplomate of the American Board of Toxicology and a full member of the Society of Toxicology.
At AIBMR Life Sciences, Dr. Murbach applies critical evaluation in reviewing and interpreting scientific studies in terms of safety and toxicological parameters, mechanisms of action, clinical applications, bioactivities, and efficacy and then delivers polished client reports and regulatory submissions using highly honed technical writing skills. He has been an author on multiple peer-reviewed journal articles related to the toxicological evaluation of food ingredients, and his work at AIBMR is focused on the preparation of safety assessment dossiers for independent conclusions of general recognized as safe (GRAS) status, FDA GRAS notices, and FDA new dietary ingredient notifications. His familiarity and understanding of the U.S. food regulatory framework provides clients with expert support for their regulatory compliance needs.
Prior to his work at AIBMR, Dr. Murbach practiced primary care naturopathic medicine at both the Integrative Medical Group of Irvine, in Irvine California, and Salem Natural Medicine, in Salem, Oregon following a one-year heart and lung rotation at the Center for Natural Medicine during his internship and a clinical residency in IV micronutrient therapy at Tigard Holistic Health Clinic. He has also been an adjunct faculty member at the Helfgott Research Institute in Portland, Oregon, and participated in Oregon Health & Science University’s Human Investigations Program (an NIH CTSA grant funded program), where he developed a Parkinson disease study grant proposal. Dr. Murbach also served on the American Association of Naturopathic Physicians Electronic Health Records Task Force.
For many years, Dr. Murbach has given hundreds of hours of volunteer service to the Northwest Naturopathic Physicians Convention, the American Association of Naturopathic Physicians, an IV micronutrient therapy list serv, and to a range of community outreach organizations, including United Way (Oregon) and Cante Wanji (Colorado).
Philip Palmer, MS, RD
Senior Scientific and Regulatory Consultant
Philip Palmer, M.S., R.D., is a Senior Scientific and Regulatory Consultant for AIBMR Life Sciences. He is an integral part of AIBMR Life Sciences’ core research team. Phil provides technical support for the evaluation of the safety, quality, and efficacy of natural products. He is highly skilled in scientific literature searching and in the writing of technical reports. He also provides critical support to our regulatory compliance team.Read More
Philip Palmer, MS, RDN, is a Senior Scientific and Regulatory Consultant for AIBMR Life Sciences. He earned both a Bachelor’s degree in the Natural Health Sciences and a Master of Science in Nutrition from Bastyr University in Kenmore, Washington. Spending a post-graduate year in Alaska, he completed a Dietetic Internship through the University of Alaska, giving him a spectrum of experience in public health and clinical settings. Now a Registered Dietitian Nutritionist, he is a former chef and graduate of the Natural Gourmet Institute in New York, NY.
In his previous role as a Research Coordinator, Phil garnered an understanding of challenges encountered in clinical trials, knowledge that he now applies in critically evaluating published research. He managed food and dietary ingredient clinical trials conducted at academic and healthcare institutions investigating diabetes, macronutrient balance versus metabolism, pulses (dried peas, edible beans, lentils and chickpeas), glutathione, and carotenoids. His areas of particular interest include n-3 fatty acids, phytochemicals, and the psychology of eating behaviors.
An integral part of AIBMR Life Sciences’ core research team, Phil evaluates the safety, quality, and efficacy of natural products, and applies knowledge of appropriate scientific literature in the writing of technical reports. Phil also serves numerous functions as part of our regulatory compliance team.
Robin Reddeman, ND
Scientific and Regulatory Consultant
Robin Reddeman, ND is a Scientific and Regulatory Consultant at AIBMR. Dr. Reddeman earned her Doctor of Naturopathic Medicine degree at Bastyr University in Seattle, Washington in 2007. She then completed a one-year residency at Bastyr Center for Natural Health. Her clinical rotations included caring for patients with HIV, endocrine issues, musculoskeletal conditions, and providing primary care. During her years as Bastyr adjunct faculty, Dr. Reddeman supervised shifts providing naturopathic care to low-income and homeless women as well as physical medicine and primary care. She also instructed students on research-supported use of nutrient and herbal therapies.Read More
In addition to her tenure as a clinical supervisor, Dr. Reddeman also has years of experience serving patients in private practice where she continued clinical application of natural medicines such as botanicals, physical medicine modalities and nutrient therapy in holistically treating people with musculoskeletal, endocrine and digestive issues.
As Scientific and Regulatory Consultant at AIBMR Life Sciences, Dr. Reddeman utilizes her well-developed critical thinking skills and attention to detail in performing literature reviews and analyzing scientific studies for evaluating the safety, quality and intended use of substances for attaining regulatory status in the US. She writes thorough scientific dossiers and reports, integrating all aspects of relevant information.
Director of Finance & Operations
In 1995, Laura became Operations Director of AIBMR’S Life Sciences Division and after three years was promoted to Chief Financial Officer and Chief Operations Officer. In these roles, Laura provides overall leadership for AIBMR’s finance department and is a key member of the company’s leadership team.Read More
Laura’s 30 years of experience in the natural products industry began with her sales position at the Natural Products Store, now known as Marlene’s Market & Deli, a two-time national winner of “Store of the Year” in its respective category.
Laura’s success in natural products sales attracted the attention of major national dietary supplement manufacturers. She was offered a sales position by KAL, at that time a leading U.S. dietary supplement manufacturer, and relocated to Boston. Laura so quickly and successfully built KAL’s New England territory that she was soon offered a promotion to Product Training Manager for the Naturally, Inc.
Over many years of attending natural product trade shows, Laura always made a point of attending presentations given by AIBMR Life Sciences staff. Inspired by AIBMR Life Sciences research, she applied to work for AIBMR Life Sciences and was hired in 1984 by its publications division, which included Biosocial Publications and the award-winning Life Sciences Press and eventually became the Director of Publishing. During her tenure, she was responsible for the timely publication of a quarterly, peer-reviewed scientific journal as well as many other research publications. Additionally, Laura managed Tacoma Printing Company, AIBMR’s printing division, and established accounts with major book distributors throughout North America.
From 1991 to 1995, Laura was the Operations Director for two national non-profit organizations, Citizens For Health (CHF) and the American Preventive Medical Association (APMA). Her responsibilities included office and human resources management, as well as editorial management of the organizations’ membership newsletters. In 1994, CHF achieved national recognition by winning the “Award of Excellence in Government Relations”, a Federal lobbying award given by the 25,000-member American Society of Association Executives in recognition of its role in successfully organizing national grass roots support for the hotly-contested Dietary Supplement Health and Education Act of 1994, which eventually passed and become law. Laura also worked with APMA to introduce the Access to Medical Freedom Act in Congress, and her leadership was recognized and awarded by the natural products industry.
In 1995, Laura became Operations Director of AIBMR’S Life Sciences Division and after three years was promoted to Chief Financial Officer and Chief Operations Officer. In these roles, Laura provides overall leadership for AIBMR’s finance department and is a key member of the company’s leadership team.
Jared D. Brodin
Director of Information Services
As AIBMR’s Director of Information Services, Jared’s detail includes involvement in corporate marketing and branding strategies, directorship of the firm’s extensive library holdings and acquisitions, coordination of major research projects, and oversight of social media and website functions.